VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the expansion of its Nu.Q® Vet Cancer Test supply agreement (the "Agreement") with Fujifilm ...
Zacks Small Cap Research on MSN10d
VNRX: Additional clinical papers & company webinars provide insights to Volition’s progress. Nu.Q Discover biomarkers selected for clinical trial. Management continue…VNRX READ THE FULL VNRX RESEARCH REPORT RECENT EVENTS Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025 ...
VolitionRx (VNRX) announced the expansion of its Nu.Q Vet Cancer Test supply agreement with Fujifilm Vet Systems in Japan, to include ...
HENDERSON, Nev., March 11, 2025 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces first patient enrollment in a clinical study ...
When the fishing vessel Volition broke up on the night of 27 February after running aground very early that day, Bermagui ...
GMA Network on MSN5d
Rodrigo Duterte on Villamor detention: ‘I was brought here not out of my own volition’Former President Rodrigo Duterte on Tuesday questioned why he was being detained at the Villamor Air Base following his ...
Volition a multi-national epigenetics company, announces its first commercial sale of Volition's High Throughput Synthetic Sepsis method that measures Neutrophil Extracellular Traps "NETs" activation ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, Volition is pleased to announce our participation in the 97th Annual Western Veterinary Conference (WVC), ...
"The Nu.Q® Cancer test could support physicians with clinical decision-making following LDCT by identifying the patients at highest risk and whose nodules are more likely to be cancerous, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback